THE INTERNATIONAL PROGNOSTIC INDEX IS ASSOCIATED WITH OUTCOMES IN DIFFUSE LARGE B CELL LYMPHOMA AFTER CAR T CELL THERAPY

CD19-targeted chimeric antigen receptor T cells (CAR T cells) have shown excellent activity against relapsed and refractory (R/R) diffuse large B-cell lymphoma (DLBCL). CAR T cell therapy is associated with early toxicities, including cytokine release syndrome and neurotoxicity. The incidence and se...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transplant Cell Ther
Main Authors: Garcia-Recio, Marta, Wudhikarn, Kitsada, Pennisi, Martina, Alonso-Trillo, Rosalia, Flynn, Jessica, Shouval, Roni, Afuye, Aishat O., Silverberg, Mari Lynne, Batlevi, Connie W, Parastoo, Dahi, Devlin, Sean, Giralt, Sergio, Halton, Elizabeth, Ruiz, Josel, Maloy, Molly, Mead, Elena, Palomba, Lia, Santomasso, Bianca, Sauter, Craig S, Scordo, Michael, Gunjan, Shah, Perales, Miguel-Angel
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8010220/
https://ncbi.nlm.nih.gov/pubmed/33781518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtct.2020.10.022
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados